Vyriad Competitors and Similar CompaniesClear all
ALX Oncology's competitors and similar companies include Seagen.
 ALX Oncology ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment. |  Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. | |
Founding Date | Founding Date 2015 | Founding Date 1998 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Burlingame, US HQ Dublin 2, IE | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more |
Employees | Employees 743% increase | Employees 3,25622% increase |
Financial | ||
Net income | Net income ($101.7m) (FY, 2025) | Net income ($610.3m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 166m | Total funding raised $ 164m |
For sources of this data, please see the company profile
View Company Profiles
Seagen
HQ
Bothell, US
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View company